Lujun Shen

Lujun Shen

Department of Minimally Invasive Therapy, Sun Yat-sen University Cancer Center

Affiliated withSun Yat-sen University Cancer Center

Research Area

Biography

Lujun Shen has not added Biography.
If you are Lujun Shen and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein
Publication title
2026

Other Publications

Article
Year
Alternative endpoints to the 5-year overall survival and locoregional control for nasopharyngeal carcinoma: A retrospective analysis of 2,450 patients.

Molecular and clinical oncology| PubMed ID: 24772305

2014
Gene therapy for unresectable hepatocellular carcinoma using recombinant human adenovirus type 5.

Medical oncology (Northwood, London, England)| PubMed ID: 24990099

2014
2015
2015
2015
2015
2015
2015
2016
2016
2016
2016
2016
2016
2016
2016
2016
2017
Percutaneous CT-guided radiofrequency ablation for patients with extrahepatic oligometastases of hepatocellular carcinoma: long-term results.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group| PubMed ID: 28540809

2018
2017
High number of PD-1 positive intratumoural lymphocytes predicts survival benefit of cytokine-induced killer cells for hepatocellular carcinoma patients.

Liver international : official journal of the International Association for the Study of the Liver| PubMed ID: 29356308

2018
2018
2018
2018
2018
2018
2019
2018
2019
2019
2019
2019
2019
2019
2019
2019
2019
2020
2019
Efficacy and safety of CT-guided percutaneous thermal ablation for hepatocellular carcinoma adjacent to the second porta hepatis.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group| PubMed ID: 31739695

2019
2019
2019
2019
2020
2020
Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group| PubMed ID: 32323585

2020
2020
2020
2020
2020
2020
2020
2020
2020
2020
2020
2020
2020
Single-nodule hepatitis B virus-associated hepatocellular carcinoma smaller than 3 cm: two phenotypes defined by cluster analysis and their association with the outcome of ablation as the fi...

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group| PubMed ID: 33541160

2021
2021
2021
2021
2021
2021
Comparison between surgery and thermal ablation for adrenal metastases: a retrospective study.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group| PubMed ID: 34727828

2021
2021
2021
2021
2022
2022
2021
2022
Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group| PubMed ID: 35853727

2022
2022
2023
2023
2023
Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 37184976

2023
2023
2023
2024
2024
2025
2024
2024
2025
2025
2025
2025
The Value of no Evidence of Disease (NED) in Intermediate-Stage Hepatocellular Carcinoma After TACE: A Real-World Study.

Liver international : official journal of the International Association for the Study of the Liver| PubMed ID: 40231897

2025
2025
2025
2025
2025
2025
2025
2025
2025
2025
2025